2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
RESTRICTED
Published on
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASDThe Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD) European Heart Journal 2020;42:255-323These guidelines provide direction on the management and prevention of cardiovascular disease (CVD) in subjects with, an...
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
RESTRICTED
Published on
The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)European Heart Journal, 2020Publication of this update to the 2016 guidelines follows emergence of a substantial body of evidence pertaining to low-density lipoprotein-C (LDL-C) reductions and risk of atherosclerotic cardiovascular disease (ASCVD). Monitoring LDL-C for longer periods is now required, with new g...
Cardiovascular disease and risk management: standards of care in diabetes – 2020
RESTRICTED
Published on
American Diabetes AssociationDiabetes Care, 2020The American Diabetes Association (ADA) Standards of Medical Care in Diabetes outlines current clinical practice recommendations for diabetes care, including treatment goals, tools to evaluate quality of care and recommendations for lipid profile monitoring (which can be conducted via POC testing). The guidelines recommend obtaining a lipid profile at the time of diabetes diagnosis, at an initial me...
